EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieOpen Access

Effect of the Xanthine Oxidase Inhibitor, Febuxostat, on WBC Count in Asymptomatic Hyperuricemia: Subanalysis of the Randomized PRIZE Study

Mitsuhide Takeshita, Atsushi Tanaka, Hisako Yoshida, Ikuko Nakamura, Yoshisato Shibata, Shiro Hata, Akifumi Kushiyama, Masaaki Okutsu, Tomoko Ishizu, Koichi Node

Journal of Atherosclerosis and Thrombosis · 2024

DOI: 10.5551/jat.64574 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Atherosclerosis and Thrombosis, 2024. Verfasst von Mitsuhide Takeshita und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, Saga University. Hauptthemen laut MEDLINE: Febuxostat, Hyperuricemia, Xanthine Oxidase. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FebuxostatHyperuricemiaXanthine OxidaseHumansMaleFemaleMiddle AgedLeukocyte CountProspective StudiesGout SuppressantsAgedBiomarkersFollow-Up StudiesC-Reactive ProteinUric Acid

Stichwörter der Autor:innen

Asymptomatic hyperuricemiaFebuxostatInflammationWBC count

Substanzen

FebuxostatXanthine OxidaseGout SuppressantsBiomarkersC-Reactive ProteinUric Acid

Autor:innen und Institutionen

  • Department of Cardiovascular Medicine, Saga University.
  • Department of Medical Statistics, Osaka Metropolitan University Graduate School of Medicine.
  • Department of Cardiovascular Medicine, Saga-Ken Medical Centre Koseikan.
  • Department of Cardiology, Miyazaki Medical Association Hospital.
  • Department of Cardiology, Sasebo City General Hospital.
  • Department of Pharmacotherapy, Meiji Pharmaceutical University.

Zitieren

APA

Takeshita, M., Tanaka, A., Yoshida, H., Nakamura, I., Shibata, Y., Hata, S., Kushiyama, A., Okutsu, M., Ishizu, T., & Node, K. (2024). Effect of the Xanthine Oxidase Inhibitor, Febuxostat, on WBC Count in Asymptomatic Hyperuricemia: Subanalysis of the Randomized PRIZE Study. Journal of Atherosclerosis and Thrombosis. https://doi.org/10.5551/jat.64574

Vancouver

Takeshita M, Tanaka A, Yoshida H, Nakamura I, Shibata Y, Hata S, et al. Effect of the Xanthine Oxidase Inhibitor, Febuxostat, on WBC Count in Asymptomatic Hyperuricemia: Subanalysis of the Randomized PRIZE Study. Journal of Atherosclerosis and Thrombosis. 2024. doi:10.5551/jat.64574

BibTeX
@article{Takeshita2024,
  author = {Takeshita, Mitsuhide and Tanaka, Atsushi and Yoshida, Hisako and Nakamura, Ikuko and Shibata, Yoshisato and Hata, Shiro and Kushiyama, Akifumi and Okutsu, Masaaki and Ishizu, Tomoko and Node, Koichi},
  title = {Effect of the Xanthine Oxidase Inhibitor, Febuxostat, on WBC Count in Asymptomatic Hyperuricemia: Subanalysis of the Randomized PRIZE Study},
  journal = {Journal of Atherosclerosis and Thrombosis},
  year = {2024},
  doi = {10.5551/jat.64574}
}
Kostenlos starten →